{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:45:41Z","timestamp":1792043141383,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"DOI":"10.1007\/s12928-026-01359-y","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:56:25Z","timestamp":1792040185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal patterns of the association between Achilles tendon thickening and clinical outcomes after percutaneous coronary intervention in acute and chronic coronary syndromes"],"prefix":"10.1007","author":[{"given":"Kaori","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2888-6160","authenticated-orcid":false,"given":"Hideki","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/01.CIR.79.2.225","volume":"79","author":"H Mabuchi","year":"1989","unstructured":"Mabuchi H, Koizumi J, Shimizu M, Takeda R. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 1989;79:225\u201332.","journal-title":"Circulation"},{"key":"1359_CR2","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.jacc.2019.02.059","volume":"73","author":"A Singh","year":"2019","unstructured":"Singh A, Gupta A, Collins BL, Qamar A, Monda KL, Biery D, et al. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2019;73:2439\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"1359_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jacl.2021.04.005","volume":"15","author":"B Kheiri","year":"2021","unstructured":"Kheiri B, Simpson TF, Osman M, Balla S, Rahmouni H, Mehta A, et al. Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomes. J Clin Lipidol. 2021;15:460\u20135.","journal-title":"J Clin Lipidol"},{"key":"1359_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2016.03.023","volume":"249","author":"LS Rallidis","year":"2016","unstructured":"Rallidis LS, Triantafyllis AS, Tsirebolos G, Katsaras D, Rallidi M, Moutsatsou P, et al. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins. Atherosclerosis. 2016;249:17\u201321.","journal-title":"Atherosclerosis"},{"key":"1359_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jacl.2020.03.008","volume":"14","author":"N Danchin","year":"2020","unstructured":"Danchin N, Farnier M, Zeller M, Puymirat E, Cottin Y, Belle L, et al. Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program. J Clin Lipidol. 2020;14:352\u2013e3606.","journal-title":"J Clin Lipidol"},{"key":"1359_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","volume":"303","author":"Risk of fatal","year":"1991","unstructured":"Risk of fatal. coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991;303:893\u20136.","journal-title":"BMJ"},{"key":"1359_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.5551\/jat.GL2017","volume":"25","author":"M Kinoshita","year":"2018","unstructured":"Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, et al. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb. 2018;25:846\u2013984.","journal-title":"J Atheroscler Thromb"},{"key":"1359_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-2004-822987","volume":"4","author":"JC Defesche","year":"2004","unstructured":"Defesche JC, Lansberg PJ, Umans-Eckenhausen MA, Kastelein JJ. Advanced method for the identification of patients with inherited hypercholesterolemia. Semin Vasc Med. 2004;4:59\u201365.","journal-title":"Semin Vasc Med"},{"key":"1359_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5551\/jat.11.146","volume":"11","author":"H Bujo","year":"2004","unstructured":"Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, et al. Clinical features of familial hypercholesterolemia in Japan in a database from 1996\u20131998 by the research committee of the ministry of health, labour and welfare of Japan. J Atheroscler Thromb. 2004;11:146\u201351.","journal-title":"J Atheroscler Thromb"},{"key":"1359_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1536\/ihj.16-188","volume":"58","author":"H Ohmura","year":"2017","unstructured":"Ohmura H, Fukushima Y, Mizuno A, Niwa K, Kobayashi Y, Ebina T, et al. Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome. Int Heart J. 2017;58:88\u201394.","journal-title":"Int Heart J"},{"key":"1359_CR11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.5551\/jat.37770","volume":"24","author":"T Harada","year":"2017","unstructured":"Harada T, Inagaki-Tanimura K, Nagao M, Sato Y, Sudo M, Okajima F, et al. Frequency of Achilles Tendon Xanthoma in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2017;24:949\u201353.","journal-title":"J Atheroscler Thromb"},{"key":"1359_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.atherosclerosis.2018.06.856","volume":"277","author":"M Harada-Shiba","year":"2018","unstructured":"Harada-Shiba M, Ako J, Arai H, Hirayama A, Murakami Y, Nohara A, et al. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study. Atherosclerosis. 2018;277:362\u20138.","journal-title":"Atherosclerosis"},{"key":"1359_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00380-019-01400-6","volume":"34","author":"H Kitahara","year":"2019","unstructured":"Kitahara H, Mori N, Saito Y, Nakayama T, Fujimoto Y, Kobayashi Y. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention. Heart Vessels. 2019;34:1595\u20139.","journal-title":"Heart Vessels"},{"key":"1359_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jjcc.2020.01.002","volume":"75","author":"H Kitahara","year":"2020","unstructured":"Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention. J Cardiol. 2020;75:654\u20138.","journal-title":"J Cardiol"},{"key":"1359_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jjcc.2021.11.013","volume":"79","author":"H Kitahara","year":"2022","unstructured":"Kitahara H, Yamazaki T, Hiraga T, Yamashita D, Matsumoto T, Kobayashi T, et al. Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease. J Cardiol. 2022;79:559\u201363.","journal-title":"J Cardiol"},{"key":"1359_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00380-020-01679-w","volume":"36","author":"T Hashimoto","year":"2021","unstructured":"Hashimoto T, Minami Y, Asakura K, Katamine M, Kato A, Katsura A, et al. Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease. Heart Vessels. 2021;36:163\u20139.","journal-title":"Heart Vessels"},{"key":"1359_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.5551\/jat.63607","volume":"30","author":"I Matsumoto","year":"2023","unstructured":"Matsumoto I, Kurozumi M, Namba T, Takagi Y. Achilles Tendon Thickening as a Risk Factor of Cardiovascular Events after Percutaneous Coronary Intervention. J Atheroscler Thromb. 2023;30:491\u2013501.","journal-title":"J Atheroscler Thromb"},{"key":"1359_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jjcc.2023.07.007","volume":"82","author":"T Isawa","year":"2023","unstructured":"Isawa T, Horie K, Toyoda S, Taguri M. Prognostic impact of Achilles tendon thickness in elderly patients after percutaneous coronary intervention: A 5-year follow-up. J Cardiol. 2023;82:448\u201354.","journal-title":"J Cardiol"},{"key":"1359_CR19","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720\u2013826.","journal-title":"Eur Heart J"},{"key":"1359_CR20","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415\u2013537.","journal-title":"Eur Heart J"},{"key":"1359_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12928-024-01036-y","volume":"39","author":"Y Ozaki","year":"2024","unstructured":"Ozaki Y, Tobe A, Onuma Y, Kobayashi Y, Amano T, Muramatsu T, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024. Cardiovasc Interv Ther. 2024;39:335\u201375.","journal-title":"Cardiovasc Interv Ther"},{"key":"1359_CR22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12928-024-01020-6","volume":"39","author":"T Kawamoto","year":"2024","unstructured":"Kawamoto T, Otsuki H, Arashi H, Jujo K, Oka T, Mori F, et al. Adverse clinical events after percutaneous coronary intervention in very elderly patients with acute coronary syndrome. Cardiovasc Interv Ther. 2024;39:438\u201347.","journal-title":"Cardiovasc Interv Ther"},{"key":"1359_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s12928-025-01137-2","volume":"40","author":"K Wakabayashi","year":"2025","unstructured":"Wakabayashi K, Yonetsu T, Mizukami T, Yamamoto MH, Yasuhara S, Shishido K, et al. Feasibility of optical coherence tomography-guided primary percutaneous coronary intervention for STEMI: all-comer ATLAS-OCT trial. Cardiovasc Interv Ther. 2025;40:576\u201387.","journal-title":"Cardiovasc Interv Ther"},{"key":"1359_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12928-025-01116-7","volume":"40","author":"K Kakehi","year":"2025","unstructured":"Kakehi K, Ueno M, Yamada N, Onishi K, Sugimoto K, Funauchi Y, et al. Incremental value of physiological indices to predict high-risk plaques detected by NIRS-IVUS. Cardiovasc Interv Ther. 2025;40:588\u201398.","journal-title":"Cardiovasc Interv Ther"},{"key":"1359_CR25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1253\/circj.CJ-25-0710","volume":"90","author":"K Abe","year":"2026","unstructured":"Abe K, Kitahara H, Tateishi K, Saito Y, Kato K, Kobayashi Y. Prognostic Impact of Achilles Tendon Thickening After Percutaneous Coronary Intervention Compared Between Acute and Chronic Coronary Syndromes. Circ J. 2026;90:1107\u20139.","journal-title":"Circ J"},{"key":"1359_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5551\/jat.GL2022","volume":"31","author":"T Okamura","year":"2024","unstructured":"Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, et al. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb. 2024;31:641\u2013853.","journal-title":"J Atheroscler Thromb"},{"key":"1359_CR27","first-page":"e618","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Univers Definition Myocard Infarct (2018) Circulation. 2018;138:e618\u201351.","journal-title":"Fourth Univers Definition Myocard Infarct (2018) Circulation"},{"key":"1359_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCIMAGING.112.973701","volume":"5","author":"K Kato","year":"2012","unstructured":"Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5:433\u201340.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1359_CR29","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0140-6736(19)31794-5","volume":"394","author":"R Waksman","year":"2019","unstructured":"Waksman R, Di Mario C, Torguson R, Ali ZA, Singh V, Skinner WH, et al. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. Lancet. 2019;394:1629\u201337.","journal-title":"Lancet"},{"key":"1359_CR30","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/eurheartj\/ehaa227","volume":"41","author":"M Tomaniak","year":"2020","unstructured":"Tomaniak M, Katagiri Y, Modolo R, de Silva R, Khamis RY, Bourantas CV, et al. Vulnerable plaques and patients: state-of-the-art. Eur Heart J. 2020;41:2997\u20133004.","journal-title":"Eur Heart J"},{"key":"1359_CR31","doi-asserted-by":"publisher","first-page":"132365","DOI":"10.1016\/j.ijcard.2024.132365","volume":"415","author":"L Di Vito","year":"2024","unstructured":"Di Vito L, Di Giusto F, Mazzotta S, Scalone G, Bruscoli F, Silenzi S, et al. Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms. Int J Cardiol. 2024;415:132365.","journal-title":"Int J Cardiol"},{"key":"1359_CR32","doi-asserted-by":"publisher","first-page":"e007174","DOI":"10.1161\/JAHA.117.007174","volume":"7","author":"C Varenhorst","year":"2018","unstructured":"Varenhorst C, Hasvold P, Johansson S, Janzon M, Albertsson P, Leosdottir M, et al. Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies). J Am Heart Assoc. 2018;7:e007174.","journal-title":"J Am Heart Assoc"},{"key":"1359_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","volume":"397","author":"D Erlinge","year":"2021","unstructured":"Erlinge D, Maehara A, Ben-Yehuda O, B\u00f8tker HE, Maeng M, Kj\u00f8ller-Hansen L, et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet. 2021;397:985\u201395.","journal-title":"Lancet"},{"key":"1359_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ijcard.2012.04.011","volume":"167","author":"RF Alcock","year":"2013","unstructured":"Alcock RF, Yong AS, Ng AC, Chow V, Cheruvu C, Aliprandi-Costa B, et al. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort. Int J Cardiol. 2013;167:1343\u20136.","journal-title":"Int J Cardiol"},{"key":"1359_CR35","doi-asserted-by":"publisher","first-page":"8907315","DOI":"10.1155\/2023\/8907315","volume":"2023","author":"Q Landolff","year":"2023","unstructured":"Landolff Q, Quillot M, Picard F, Henry P, Sideris G, Bizeau O, et al. In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease. J Interv Cardiol. 2023;2023:8907315.","journal-title":"J Interv Cardiol"},{"key":"1359_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/eurjhf\/hfq194","volume":"13","author":"JJ Thune","year":"2011","unstructured":"Thune JJ, Signorovitch JE, Kober L, McMurray JJ, Swedberg K, Rouleau J, et al. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. Eur J Heart Fail. 2011;13:148\u201353.","journal-title":"Eur J Heart Fail"},{"key":"1359_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/heartjnl-2020-317165","volume":"107","author":"J Song","year":"2020","unstructured":"Song J, Murugiah K, Hu S, Gao Y, Li X, Krumholz HM, et al. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart. 2020;107:313\u20138.","journal-title":"Heart"},{"key":"1359_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12928-024-00994-7","volume":"39","author":"Y Minami","year":"2024","unstructured":"Minami Y, Ako J, Tsujita K, Yokoi H, Ikari Y, Morino Y, et al. Drug intervention as an emerging concept for secondary prevention in patients with coronary disease. Cardiovasc Interv Ther. 2024;39:223\u201333.","journal-title":"Cardiovasc Interv Ther"},{"key":"1359_CR39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12928-024-01000-w","volume":"39","author":"G Yoshioka","year":"2024","unstructured":"Yoshioka G, Tanaka A, Sonoda S, Kaneko T, Hongo H, Yokoi K, et al. Importance of reassessment to identify trajectories of chronic transition of clinical indicators in post-myocardial infarction management. Cardiovasc Interv Ther. 2024;39:234\u201340.","journal-title":"Cardiovasc Interv Ther"},{"key":"1359_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","volume":"170","author":"R Mathews","year":"2015","unstructured":"Mathews R, Wang TY, Honeycutt E, Henry TD, Zettler M, Chang M, et al. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. Am Heart J. 2015;170:62\u20139.","journal-title":"Am Heart J"},{"key":"1359_CR41","doi-asserted-by":"publisher","first-page":"e005041","DOI":"10.1161\/CIRCOUTCOMES.118.005041","volume":"12","author":"AM Navar","year":"2019","unstructured":"Navar AM, Roe MT, White JA, Cannon CP, Lokhnygina Y, Newby LK, et al. Medication Discontinuation in the IMPROVE-IT Trial. Circ Cardiovasc Qual Outcomes. 2019;12:e005041.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1359_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.amjcard.2023.09.047","volume":"207","author":"K Yamamoto","year":"2023","unstructured":"Yamamoto K, Morimoto T, Natsuaki M, Shiomi H, Ogita M, Tada T, et al. Statin Discontinuation After Coronary Revascularization. Am J Cardiol. 2023;207:479\u201389.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-026-01359-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:56:26Z","timestamp":1792040186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-026-01359-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":42,"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s12928-026-01359-y","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"11 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests or personal relationships that may have influenced the research reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yoshio Kobayashi is the Editor-in-Chief of Cardiovascular Intervention and Therapeutics.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Chiba University Graduate School of Medicine, Chiba, Japan (unique identifier: HK202405-15).","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}